These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 16927678)

  • 1. Impact of hemorheological and endothelial factors on microcirculation.
    Turchetti V; Boschi L; Donati G; Trabalzini L; Forconi S
    Adv Exp Med Biol; 2006; 578():107-12. PubMed ID: 16927678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium and hemorheology.
    Turchetti V; Boschi L; Donati G; Borgogni G; Coppola D; Dragoni S; Bellini MA; Sicuro S; Mastronuzzi VM; Forconi S
    Clin Hemorheol Microcirc; 2004; 30(3-4):289-95. PubMed ID: 15258356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of oxygen supply, hemorheology and microcirculation in the heart and vascular systems.
    Cicco G; Cicco S
    Adv Exp Med Biol; 2010; 662():33-9. PubMed ID: 20204768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Outlook for clinical hemorheology].
    Stoltz JF
    J Mal Vasc; 1996; 21(1):7-15. PubMed ID: 8656093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of the markers of endothelial dysfunction and hemorheological disorders for assessing the activity and prognosis of chronic glomerulonephritis].
    Smyr KV; Shcherbak AV; Kozlovskaia LV; Sokolova IA; Bobkova IN; Podorol'skaia LV
    Ter Arkh; 2010; 82(1):47-51. PubMed ID: 20364701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemorheological changes in microcirculation: their mechanism and measurement technique.
    Mchedlishvili G
    Indian J Exp Biol; 2007 Jan; 45(1):32-40. PubMed ID: 17249325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemorheology and vascular control mechanisms.
    Baskurt OK; Yalcin O; Meiselman HJ
    Clin Hemorheol Microcirc; 2004; 30(3-4):169-78. PubMed ID: 15258340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The estimation of microcirculation state in cerebrovascular disorders by data of laser Doppler flowmetry and hemorheological parameters].
    Tikhomirova IA; Mikhaĭlova SG; Lychenko SV; Osliakova AO
    Fiziol Cheloveka; 2012; 38(1):69-76. PubMed ID: 22567838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelium and hemorheology.
    Forconi S; Gori T
    Clin Hemorheol Microcirc; 2013; 53(1-2):3-10. PubMed ID: 22951621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension.
    Okubo K; Hayashi K; Wakino S; Matsuda H; Kubota E; Honda M; Tokuyama H; Yamamoto T; Kajiya F; Saruta T
    Hypertens Res; 2005 Feb; 28(2):181-9. PubMed ID: 16025746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule.
    Fliser D
    Eur J Clin Invest; 2005 Feb; 35(2):71-9. PubMed ID: 15667575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between protective effects of rosiglitazone on endothelium and endogenous nitric oxide synthase inhibitor in streptozotocin-induced diabetic rats and cultured endothelial cells.
    Wang S; Jiang JL; Hu CP; Zhang XJ; Yang DL; Li YJ
    Diabetes Metab Res Rev; 2007 Feb; 23(2):157-64. PubMed ID: 16770837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction in human disease.
    Drexler H; Hornig B
    J Mol Cell Cardiol; 1999 Jan; 31(1):51-60. PubMed ID: 10072715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
    Yamagishi S; Ueda S; Okuda S
    Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute endotoxemia inhibits microvascular nitric oxide-dependent vasodilation in humans.
    Engelberger RP; Pittet YK; Henry H; Delodder F; Hayoz D; Chioléro RL; Waeber B; Liaudet L; Berger MM; Feihl F
    Shock; 2011 Jan; 35(1):28-34. PubMed ID: 20577147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects and influencing factors on hemorheological variables taken into consideration in surgical pathophysiology research.
    Nemeth N; Deak A; Szentkereszty Z; Peto K
    Clin Hemorheol Microcirc; 2018; 69(1-2):133-140. PubMed ID: 29630533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microcirculation hemorheology and tissue oxygenation in clinical and experimental practice: CEMOT activity in the last two years.
    Cicco G
    Adv Exp Med Biol; 2006; 578():1-9. PubMed ID: 16927662
    [No Abstract]   [Full Text] [Related]  

  • 19. Rheologic considerations in organ preservation.
    Boyle EM; Verrier ED
    Ann Thorac Surg; 2000 Jan; 69(1):12-3. PubMed ID: 10654478
    [No Abstract]   [Full Text] [Related]  

  • 20. Fahraeus Lecture 2005: Hemorheology and vascular diseases: red cell should rub up to the wall, leucocytes should cope with it.
    Boisseau MR
    Clin Hemorheol Microcirc; 2006; 35(1-2):11-6. PubMed ID: 16899901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.